NewsEuropeGerman Medical Cannabis Scripts Mainly For Pain

German Medical Cannabis Scripts Mainly For Pain

-

PAIN is most common ailment for which patients are prescribed medical cannabis, say the German Government 

The introduction of its medical cannabis programme in 2017 saw physicians allowed to prescribe medicinal cannabis for over 60 illnesses.

Almost three quarters of all prescriptions from a Government sample of over 6,500 are for pain – at 71%

This was followed by spasticity – a muscle condition at 11% – and anorexia at 7%, with epilepsy,  migraines, ADHD and Tourettes Syndrome all featuring, too.

The data is based on an ongoing government survey involving 6,538 patients, as of September last year, reports the Marijuana Business Daily website.

This survey on the medical market will run until March 2022 and will then be used determine the future of medical cannabis insurance coverage.

Germany’s medical cannabis programme began in March 2017, and 

‘The Germany Cannabis Report’  by  Prohibition Partners  estimates 60,000 patients have been helped.

One of the most pressing issues in the German market is that it does not have the supply chain to satiate demand and has consequently granted supply licenses to three Canadian, and one domestic, producer while it  encourages the development of a homegrown industry.

This comes an estimated four million Germans use cannabis, with 17% of 18 to 25-year-olds saying they had used it in the past 12 months.

Despite being illegal, the state will not usually prosecute anyone found to have six grams of cannabis, or less – a limit agreed by state interior ministers, in 2018.

https://mjbizdaily.com/new-data-reveals-to


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are leading the fight against over-zealous German law enforcement in a...

UK CBD Consumption To Switch From Oils To Capsules – As New Research Estimates Market Value At £690m

CAPSULES are set to replace oils as the preferred method of CBD consumption - as new research show the...

Crowdfunding: An Emerging Capital Greenhouse For The Cannabis Industry

ALPHAGREEN is expected to hit close to the £2m crowdfunding mark on the Seedrs platform by mid-May – double...

Former JP Morgan Banker Lands Two UK Cannabis Jobs

A VETRAN of American investment bank JP Morgan has entered the burgeoning field of cannabis with appointments to two...

Europe’s Hemp Pioneer Posts Record Results With CBD, Construction And Car-Making To The Fore

EUROPEAN pioneer HempFlax has posted record annual results with revenues up 43% to €14.5m (£12.5m) as it returned a...

Sales Up Sharply At Sativa Wellness But Operational Costs Lead to £4.5m Loss

BRITISH CBD firm Sativa Wellness saw annual sales rise by over one-third in an eventful year which saw it...

Must read

Germany’s ‘KanaVape’ Moment As Police And Courts Crackdown On ‘Narcotic’ Hemp & CBD

TWO senior figures in the European cannabis industry are...

You might also likeRELATED
Recommended to you